Author

B. S. Ross

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:differential expression· 1 Organism:fungi (other)· 1

Frequent Co-Authors

R. A. Cramer· 5 shared J. E. Stajich· 3 shared L. A. Lofgren· 3 shared C. H. Kowalski· 2 shared J. J. Obar· 2 shared J. T. Jones· 2 shared A. Ashare· 1 shared A. K. Caffrey-Carr· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

R. A. Cramer

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

The Cystic Fibrosis treatment, Trikafta, affects growth, viability, and cell wall of Aspergillus fumigatus biofilms

J. T. Jones, K. A. Morelli, E. M. Vesely, C. Puerner, C. Pavuluri, B. S. Ross, N. v. Rhijn, M. J. Bromley, R. A. Cramer

This study shows Trikafta reduces A. fumigatus biofilm biomass, viability, and metabolic activity, while increasing susceptibility to antifungal drugs.

bioRxiv · Jun 20, 2023 · PreprintMicrobiology

Host lung environment limits Aspergillus fumigatus germination through a SskA-dependent signaling response

M. E. Kirkland, M. Stannard, C. H. Kowalski, D. L. Mould, A. K. Caffrey-Carr, R. M. Temple, B. S. Ross, L. A. Lofgren, J. E. Stajich, R. A. Cramer, J. J. Obar

The paper identifies a SskA-dependent signaling pathway that limits Aspergillus fumigatus germination in the host lung environment, enhancing disease initiation and inflammation.

bioRxiv · Aug 27, 2021Microbiology

Aspergillus fumigatus In-Host HOG pathway mutation for Cystic Fibrosis Lung Microenvironment Persistence

B. S. Ross, L. A. Lofgren, A. Ashare, J. E. Stajich, R. A. Cramer

This paper identifies a unique Pbs2 MAPKK allele in Aspergillus fumigatus isolates from CF patients that enables lung persistence by enhancing osmotic stress response in low oxygen but reducing oxidative stress resistance in standard conditions.

bioRxiv · Feb 17, 2021Microbiology

Antifungal activity of Propranolol against Fusarium keratitis isolates from the Mycotic Ulcer Treatment Trial (MUTT) and the United States.

R. Bao, B. S. Ross, C. G. Perez, G. Poimenidou, N. V. Prajna, R. A. Cramer, M. E. Zegans

This study evaluates the antifungal activity of propranolol and its enantiomers against Fusarium keratitis isolates and Aspergillus fumigatus, finding fungicidal effects and reduced MIC with natamycin.

bioRxiv · Jan 19, 2021 · PreprintMicrobiology

Strain specific persistence in the murine lung of Aspergillus fumigatus conidia causes an Allergic Broncho-Pulmonary Aspergillosis-like disease phenotype

J. T. Jones, K.-W. Liu, X. Wang, C. H. Kowalski, B. S. Ross, K. A. M. Mills, J. D. Kerkaert, T. M. Hohl, L. A. Lofgren, J. E. Stajich, J. J. Obar, R. A. Cramer

This study identifies an A. fumigatus strain, W72310, that persists in the mouse lung and causes ABPA-like disease without significant hyphal growth.

bioRxiv · Dec 4, 2020Microbiology